Clinical trials

CLINICAL TRIALS

Clinical trials

  • 1

    clinical study ongoing
    in patients

  • 7

    clinical trials
    completed

  • 679

    people enrolled so far in phase 1 and phase 2
    clinical trials

We are currently conducting the following clinical study:

StudyPhaseTitleLinks
AXBIOMEObservationalA prospective Non-Interventional Study Assessing the Impact of Antibiotics on the Efficacy of First Line Pembrolizumab based Treatment of Metastatic Non-Small Cell Lung Carcinoma

The following clinical trials have been completed:

StudyPhaseTitleLinks
DAV132-CL-2001
SHIELD Study
Phase 2A European multicenter, randomized, parallel-groups study to evaluate the safety and efficacy/performance of DAV132 in hospitalized patients at high risk for Clostridium difficile infection and who receive fluoroquinolones for the treatment of acute infectionsClinicalTrials.gov
Press Release
DAV132-CL-1006Phase 1A French, randomized, open-label study to assess the performance of DAV132, in capturing by adsorption beta-lactams without impacting the antimicrobial efficacy, while reducing the occurrence of C. difficile colonization
DAV132-CL-1004Phase 1Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy VolunteersClinicalTrials.gov
Poster
DAV132-CL-1003
DAV132-CL-1005
Phase 1Drug-drug interaction study to characterized the influence of DAV132 on pharmacokinetic parameters of concomitant drugsPress Release
DAV132-CL-1002Phase 1Safety and Efficacy Study of DAV132 in Healthy VolunteersClinicalTrials.gov
Poster
Article
DAV132-CL-1001Phase 1Pharmacokinetics study using sulfasalazine (25 mg per os, pro-drug of sulfapyridine) and amoxicillin (500 mg per os) to evaluate the effect of 7.575 g enteric-coated pellets of DAV132 on the intestinal absorption of amoxicillin and sulfapyridine in healthy subjects compared with placebo effect and with the effect of 6.077 g pellets of formulated activated charcoal Poster
Article
ANTICIPATEObservational AssessmeNT of the Incidence of Clostridium difficile Infections in Hospitalized Patients on Antibiotic TrEatmentClinicalTrials.gov
Poster